Thoroughbred Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,065	Closed	-$231K	–	338
2021 Q3	$231K	Sell	2,065 -196	-9%	-$21.9K	0.06%	285
2021 Q2	$366K	Buy	2,261 +75	+3%	+$12.1K	0.09%	210
2021 Q1	$266K	Buy	+2,186	New	+$266K	0.07%	231